Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society. 中国老年2型糖尿病防治临床指南(2022年版) [Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)]. Zhonghua nei ke za zhi. 2022;61(1):12–50. Chinese. doi:10.3760/cma.j.cn112138-20211027-00751
   PubMedGoogle Scholar
• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
   PubMed Web of Science ®Google Scholar
• Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol. 2010;65(9):963–975. doi:10.1093/gerona/glq074
   Google Scholar
• Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998;37(3):586–600. doi:10.1016/S0008-6363(97)00233-2
   PubMed Web of Science ®Google Scholar
• Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care. 2011;34(2):442–447. doi:10.2337/dc10-1087
   PubMed Web of Science ®Google Scholar
• Kida Y, Saito M, Shinohara A, et al. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone. BMC Musculoskelet Disord. 2019;20(1):627. doi:10.1186/s12891-019-3011-4
   PubMed Web of Science ®Google Scholar
• Alizargar J, Bai CH, Hsieh NC, et al. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8. doi:10.1186/s12933-019-0982-2
   PubMed Web of Science ®Google Scholar
• Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, et al. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285–294. doi:10.1016/j.arcmed.2019.08.009
   PubMed Web of Science ®Google Scholar
• Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853–872. doi:10.1002/ejhf.1170
   PubMed Web of Science ®Google Scholar
• Klajda DM, Scott CG, Rodeheffer RJ, et al. Diabetes mellitus is an independent predictor for the development of heart failure. Mayo Clinic Proc. 2020;95(1):124–133. doi:10.1016/j.mayocp.2019.07.008
   PubMed Web of Science ®Google Scholar
• Hayes AJ, Leal J, Gray AM, et al. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia. 2013;56(9):1925–1933. doi:10.1007/s00125-013-2940-y
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European Society of Cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J Card Fail. 2021;27:387–413. doi:10.1016/j.cardfail.2021.01.022
   Web of Science ®Google Scholar
• Vistoli G, De Maddis D, Cipak A, et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res. 2013;47:3–27. doi:10.3109/10715762.2013.815348
   PubMed Web of Science ®Google Scholar
• Shen CY, Lu CH, Wu CH, et al. The development of Maillard reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases. Molecules. 2020;25(23). doi:10.3390/molecules25235591
   Web of Science ®Google Scholar
• Garay-Sevilla ME, Rojas A, Portero-Otin M, et al. Dietary AGEs as exogenous boosters of inflammation. Nutrients. 2021;13(8):2802. doi:10.3390/nu13082802
   PubMed Web of Science ®Google Scholar
• Sibbersen C, Johannsen M. Dicarbonyl derived post-translational modifications: chemistry bridging biology and aging-related disease. Essays Biochem. 2020;64(1):97–110. doi:10.1042/EBC20190057
   PubMed Web of Science ®Google Scholar
• Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542. doi:10.3390/biom12040542
   PubMed Web of Science ®Google Scholar
• Menini S, Iacobini C, Ricci C, et al. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc Res. 2013;100(3):472–480. doi:10.1093/cvr/cvt206
   PubMed Web of Science ®Google Scholar
• Hu R, Wang MQ, Ni SH, et al. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol. 2020;867:172797. doi:10.1016/j.ejphar.2019.172797
   PubMed Web of Science ®Google Scholar
• Chilelli NC, Faggian A, Favaretto F, et al. In vitro chronic glycation induces AGEs accumulation reducing insulin-stimulated glucose uptake and increasing GLP1R in adipocytes. American journal of physiology. Endocrinol Metab. 2021;320(5):E976–E988. doi:10.1152/ajpendo.00156.2020
   Google Scholar
• Hirai T, Fujiyoshi K, Yamada S, et al. Advanced glycation end products are associated with diabetes status and physical functions in patients with cardiovascular disease. Nutrients. 2022;14(15):3032. doi:10.3390/nu14153032
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhu H, Ma Y, et al. AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway. Metabolism. 2021;117:154710. doi:10.1016/j.metabol.2021.154710
   PubMed Web of Science ®Google Scholar
• Liang B, Zhou Z, Yang Z, et al. AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure. Exp Physiol. 2022;107(8):879–891. doi:10.1113/EP090042
   PubMed Web of Science ®Google Scholar
• Kremers S, Remmelzwaal S, Schalkwijk CG, et al. The role of serum and dietary advanced glycation endproducts in relation to cardiac function and structure: the Hoorn Study. NMCD. 2021;31(11):3167–3175. doi:10.1016/j.numecd.2021.07.020
   PubMed Web of Science ®Google Scholar
• Paradela-Dobarro B, Fernández-Trasancos Á, Bou-Teen D, et al. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition. Cardiovasc Diabetol. 2017;16(1):115. doi:10.1186/s12933-017-0598-3
   PubMedGoogle Scholar
• Bogdanović J, Ašanin M, Krljanac G, et al. Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography. Cardiovasc Diabetol. 2019;18(1):68. doi:10.1186/s12933-019-0876-3
   PubMedGoogle Scholar
• Hu T, Gall SL, Widome R, et al. Childhood/adolescent smoking and adult smoking and cessation: the international childhood cardiovascular cohort (i3C) consortium. J Am Heart Assoc. 2020;9(7):e14381. doi:10.1161/JAHA.119.014381
   Web of Science ®Google Scholar
• Wang L, Chen F, Xiaoqi C, et al. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score. Angiology. 2021;72(2):181–186. doi:10.1177/0003319720949804
   PubMed Web of Science ®Google Scholar
• Won KB, Heo R, Park HB, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46–51. doi:10.1016/j.atherosclerosis.2021.03.009
   PubMed Web of Science ®Google Scholar
• Sadeghi M, Heshmat-Ghahdarijani K, Talaei M, et al. The predictive value of atherogenic index of plasma in the prediction of cardiovascular events; a fifteen-year cohort study. Adv Med Sci. 2021;66(2):418–423. doi:10.1016/j.advms.2021.09.003
   PubMed Web of Science ®Google Scholar
• Zheng M, Zhang X, Chen S, et al. Arterial stiffness preceding diabetes: a longitudinal study. Circ Res. 2020;127(12):1491–1498. doi:10.1161/CIRCRESAHA.120.317950
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Gu Y, et al. Relationship of noninvasive assessment of arterial stiffness with 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk in a general middle-age and elderly population. Int J Gen Med. 2021;14:6379–6387. doi:10.2147/IJGM.S330142
   PubMed Web of Science ®Google Scholar